U.S. Physical Therapy Past Earnings Performance
Past criteria checks 1/6
U.S. Physical Therapy's earnings have been declining at an average annual rate of -9.4%, while the Healthcare industry saw earnings growing at 2.7% annually. Revenues have been growing at an average rate of 11.2% per year. U.S. Physical Therapy's return on equity is 6.7%, and it has net margins of 1%.
Key information
-9.42%
Earnings growth rate
-13.84%
EPS growth rate
| Healthcare Industry Growth | 8.50% |
| Revenue growth rate | 11.20% |
| Return on equity | 6.73% |
| Net Margin | 0.97% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
Analysis Article • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...
Narrative Update • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Narrative Update • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaAnalysis Article • Sep 12
These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analysis Article • Aug 02
Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Analysis Article • Jul 11
U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analysis Article • Jun 10
Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analysis Article • May 14
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Analysis Article • Mar 24
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...Analysis Article • Mar 01
U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...Analysis Article • Feb 28
U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analysis Article • Jan 03
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Analysis Article • Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
New Narrative • Sep 14
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.Analysis Article • Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analysis Article • Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analysis Article • May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...Analysis Article • May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Analysis Article • May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Analysis Article • Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...Analysis Article • Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analysis Article • Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analysis Article • Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How U.S. Physical Therapy makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 788 | 8 | 71 | 0 |
| 31 Dec 25 | 773 | 22 | 69 | 0 |
| 30 Sep 25 | 751 | 36 | 67 | 0 |
| 30 Jun 25 | 722 | 35 | 64 | 0 |
| 31 Mar 25 | 692 | 33 | 60 | 0 |
| 31 Dec 24 | 664 | 28 | 58 | 0 |
| 30 Sep 24 | 639 | 14 | 57 | 0 |
| 30 Jun 24 | 621 | 16 | 54 | 0 |
| 31 Mar 24 | 606 | 18 | 52 | 0 |
| 31 Dec 23 | 599 | 18 | 52 | 0 |
| 30 Sep 23 | 585 | 24 | 50 | 0 |
| 30 Jun 23 | 575 | 26 | 50 | 0 |
| 31 Mar 23 | 564 | 28 | 48 | 0 |
| 31 Dec 22 | 548 | 29 | 46 | 0 |
| 30 Sep 22 | 536 | 39 | 45 | 0 |
| 30 Jun 22 | 522 | 38 | 46 | 0 |
| 31 Mar 22 | 509 | 37 | 47 | 0 |
| 31 Dec 21 | 490 | 31 | 47 | 0 |
| 30 Sep 21 | 477 | 31 | 47 | 0 |
| 30 Jun 21 | 461 | 30 | 44 | 0 |
| 31 Mar 21 | 418 | 32 | 41 | 0 |
| 31 Dec 20 | 418 | 32 | 42 | 0 |
| 30 Sep 20 | 423 | 30 | 43 | 0 |
| 30 Jun 20 | 431 | 31 | 43 | 0 |
| 31 Mar 20 | 473 | 29 | 45 | 0 |
| 31 Dec 19 | 477 | 31 | 45 | 0 |
| 30 Sep 19 | 472 | 30 | 44 | 0 |
| 30 Jun 19 | 468 | 23 | 44 | 0 |
| 31 Mar 19 | 457 | 18 | 42 | 0 |
| 31 Dec 18 | 449 | 17 | 41 | 0 |
| 30 Sep 18 | 442 | 18 | 41 | 0 |
| 30 Jun 18 | 432 | 22 | 39 | 0 |
| 31 Mar 18 | 421 | 21 | 38 | 0 |
| 31 Dec 17 | 410 | 22 | 36 | 0 |
| 30 Sep 17 | 392 | 20 | 34 | 0 |
| 30 Jun 17 | 377 | 20 | 33 | 0 |
| 31 Mar 17 | 363 | 21 | 32 | 0 |
| 31 Dec 16 | 353 | 21 | 32 | 0 |
| 30 Sep 16 | 348 | 20 | 34 | 0 |
| 30 Jun 16 | 344 | 21 | 33 | 0 |
| 31 Mar 16 | 337 | 21 | 32 | 0 |
| 31 Dec 15 | 327 | 21 | 31 | 0 |
| 30 Sep 15 | 320 | 21 | 30 | 0 |
| 30 Jun 15 | 313 | 20 | 31 | 0 |
Quality Earnings: USPH has high quality earnings.
Growing Profit Margin: USPH's current net profit margins (1%) are lower than last year (4.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: USPH's earnings have declined by 9.4% per year over the past 5 years.
Accelerating Growth: USPH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: USPH had negative earnings growth (-76.6%) over the past year, making it difficult to compare to the Healthcare industry average (16%).
Return on Equity
High ROE: USPH's Return on Equity (6.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/25 12:40 |
| End of Day Share Price | 2026/06/25 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
U.S. Physical Therapy, Inc. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |